USE OF BOUND HEPARIN IN PROLONGED EXTRACORPOREAL MEMBRANE OXYGENATION.

J. M. Toomasian, J. B. Zwischenberger, A. D. Oram, G. M. DeSmet, R. H. Bartlett

Research output: Contribution to journalConference articlepeer-review

7 Scopus citations

Abstract

Extracorporeal circulation (ECC) is utilized in the treatment of heart disease, chronic renal failure, and for extracorporeal membrane oxygenation. These procedures use systemic anticoagulation to prevent thrombosis of the artificial organs. Surface bound heparin systems have shown some promise toward eliminating the need for systemic anticoagulation. The study reported in this paper involves the use of TDMAC/heparin bonded membrane lung and components in 5 sheep supported from 30-48 hrs on venoarterial ECC. This study measures platelet count, thromboxane B//2, fibrinogen, PT, PTT, TCT, plasma hemoglobin, and fibrin degradation products to describe the hematologic changes of ECC with no supplemental heparin.

Original languageEnglish
Pages (from-to)133-136
Number of pages4
JournalTransactions - American Society for Artificial Internal Organs
Volume30
StatePublished - 1984

ASJC Scopus subject areas

  • Medicine (all)

Fingerprint

Dive into the research topics of 'USE OF BOUND HEPARIN IN PROLONGED EXTRACORPOREAL MEMBRANE OXYGENATION.'. Together they form a unique fingerprint.

Cite this